Peripheral and central administration of xenin and neurotensin suppress food intake in rodents

Obesity

Volumn 17, Issue 6, 2009, Pages 1135-1143

  Cooke, Jennifer H ^a   Patterson, Michael ^a   Patel, Sejal R ^a   Smith, Kirsty L ^a   Ghatei, Mohammad A ^a   Bloom, Stephen R ^a   Murphy, Kevin G ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; NEUROTENSIN; PEPTIDE; XENIN 25;

ANIMAL; ARTICLE; BODY WEIGHT; C57BL MOUSE; COMPARATIVE STUDY; DIET RESTRICTION; EATING; FEEDING BEHAVIOR; HYPOTHALAMUS; INFUSION PUMP; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METABOLISM; MOUSE; ORGAN CULTURE TECHNIQUE; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TIME; WISTAR RAT;

ANIMALS; BODY WEIGHT; CORTICOTROPIN-RELEASING HORMONE; EATING; FASTING; FEEDING BEHAVIOR; HYPOTHALAMUS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, SUBCUTANEOUS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED C57BL; NEUROTENSIN; ORGAN CULTURE TECHNIQUES; PEPTIDES; RATS; RATS, WISTAR; TIME FACTORS;

MUS; RATTUS; RODENTIA;

EID: 67650445631     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.652     Document Type: Article

References (49)

1. Feurle GE, Hamscher G, Kusiek R, Meyer HE, Metzger JW. Identification of xenin, a xenopsin-related peptide, in the human gastric mucosa and its effect on exocrine pancreatic secretion. J Biol Chem 1992;267:22305-22309.
2. Hamscher G, Meyer HE, Metzger JW, Feurle GE. Distribution, formation, and molecular forms of the peptide xenin in various mammals. Peptides 1995;16:791-797.
3. Carraway R, Leeman SE. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem 1973;248: 6854-6861.
4. Tyler-McMahon BM, Boules M, Richelson E. Neurotensin: peptide for the next millennium. Regul Pept 2000;93:125-136.
5. Chalon P, Vita N, Kaghad M et al. Molecular cloning of a levocabastine-sensitive neurotensin binding site. FEBS Lett 1996;386:91-94.
6. Tanaka K, Masu M, Nakanishi S. Structure and functional expression of the cloned rat neurotensin receptor. Neuron 1990;4:847-854.
7. Clemens A, Katsoulis S, Nustede R et al. Relaxant effect of xenin on rat ileum is mediated by apamin-sensitive neurotensin-type receptors. Am J Physiol 1997;272:G190-G196.
8. Anlauf M, Weihe E, Hartschuh W, Hamscher G, Feurle GE. Localization of xenin-immunoreactive cells in the duodenal mucosa of humans and various mammals. J Histochem Cytochem 2000;48:1617-1626.
9. Feurle GE, Ikonomu S, Partoulas G, Stoschus B, Hamscher G. Xenin plasma concentrations during modified sham feeding and during meals of different composition demonstrated by radioimmunoassay and chromatography Regul Pept 2003;111:153-159.
10. Feurle GE. Xenin-a review. Peptides 1998;19:609-615.
11. Feurle GE, Anlauf M, Hamscher G et al. Xenin-immunoreactive cells and extractable xenin in neuroendocrine tumors of duodenal origin. Gastroenterology 2002;123:1616-1626.
12. Feurle GE, Meyer HE, Hamscher G. Metabolism and potency of xenin and of its reduced hexapseudopeptide psi fragment in the dog. Life Sci 2003;74:697-707.
13. Alexiou C, Zimmermann JR Schick RR, Schusdziarra V. Xenin - a novel suppressor of food intake in rats. Brain Res 1998;800:294-299.
14. Levine AS, Kneip J, Grace M, Morley JE. Effect of centrally administered neurotensin on multiple feeding paradigms. Pharmacol Biochem Behav 1983;18:19-23.
15. Luttinger D, King RA, Sheppard D et al. The effect of neurotensin on food consumption in the rat. Eur J Pharmacol 1982;81:499-503.
16. Stanley BG, Hoebel BG, Leibowitz SF. Neurotensin: effects of hypothalamic and intravenous injections on eating and drinking in rats. Peptides 1983;4:493-500.
17. Sandoval SL, Kulkosky PJ. Effects of peripheral neurotensin on behavior of the rat. Pharmacol Biochem Behav 1992;41:385-390.
18. Wren AM, Small CJ, Abbott CR et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001;50:2540-2547.
19. Paxinos G, Watson C. The Rat Brain in Stereotaxic Co-ordinates, 4th edn. Elsevier: New York, 1998.
20. Scott V, Kimura N, Stark JA, Luckman SM. Intravenous peptide YY3-36 and Y2 receptor antagonism in the rat: effects on feeding behaviour. J Neuroendocrinol 2005;17:452-457.
21. Seal LJ, Small CJ, Dhillo WS et al. PRL-releasing peptide inhibits food intake in male rats via the dorsomedial hypothalamic nucleus and not the paraventricular hypothalamic nucleus. Endocrinology 2001;142: 4236-4243.
22. Stanley SA, Murphy KG, Bewick GA et al. Regulation of rat pituitary cocaine-and amphetamine-regulated transcript (CART) by CRH and glucocorticoids. Am J Physiol Endocrinol Metab 2004;287:E583-E590.
23. Dhillo WS, Small CJ, Seal LJ et al. The hypothalamic melanocortin system stimulates the hypothalamo-pituitary-adrenal axis in vitro and in vivo in male rats. Neuroendocrinology 2002;75:209-216.
24. Kim MS, Small CJ, Stanley SA et al. The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J Clin Invest 2000;105:1005-1011.
25. Ida T, Mori K, Miyazato M et al. Neuromedin s is a novel anorexigenic hormone. Endocrarology 2005;146:4217-4223.
26. Handa R, Nakazato M, Murakami N et al. A role for neuromedin U in the stress response. Biochem Biophys Res Comm 2001;289: 225-228.
27. Schwartz MW, Woods SC, Porte D Jr., Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000;404: 661-671.
28. Jethwa PH, Smith KL, Small CJ et al. Neuromedin U partially mediates leptin-induced hypothalamo-pituitary adrenal (HPA) stimulation and has a physiological role in the regulation of the HPA axis in the rat. Endocrinology 2006;147:2886-2892.
29. Uehara Y, Shimizu H, Ohtani K, Sato N, Mori M. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes 1998;47:890-893.
30. Bewick GA, Dhillo WS, Darch SJ et al. Hypothalamic cocaine- and amphetamine-regulated transcript (CART) and agouti-related protein (AgRP) neurons coexpress the NOP1 receptor and nociceptin alters CART and AgRP release. Endocrinology 2005;146:3526-3534.
31. Holst PJ, Fahrenkrug J. Neurotensin-like immunoreactivities in human plasma: feeding responses and metabolism. Peptides 1986;7: 15-20.
32. Shaw C, Buchanan KD. Intact neurotensin (NT) in human plasma: response to oral feeding. Regul Pept 1983;7:145-153.
33. Fassio A, Evans G, Grisshammer R et al. Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody. Neuropharmacology 2000;39:1430-1442.
34. Remaury A, Vita N, Gendreau S et al. Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia. Brain Res 2002;953: 63-72.
35. Gosnell BA, Morley JE, Levine AS. A comparison of the effects of corticotropin releasing factor and sauvagine on food intake. Pharmacol Biochem Behav 1983;19:771-775.
36. Hanada T, Date Y Shimbara T et al. Central actions of neuromedin U via corticotropin-releasing hormone. Biochem Biophys Res Commun 2003;311:954-958.
37. Hawkins MF, Barkemeyer CA, Tulley RT. Synergistic effects of dopamine agonists and centrally administered neurotensin on feeding. Pharmacol Biochem Behav 1986;24:1195-1201.
38. Kulkosky PJ, Gibbs J, Smith GP. Behavioral effects of bombesin administration in rats. Physiol Behav 1982;28:505-512.
39. Stuckey JA, Gibbs J. Lateral hypothalamic injection of bombesin decreases food intake in rats. Brain Res Bull 1982;8:617-621.
40. Davies BT, Wellman PJ. Effects of circadian cycle and time of testing on drug-induced anorexia in rats. Behav Pharmacol 1991;2:199-204.
41. Halford JC, Wanninayake SC, Blundell JE. Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake. Pharmacol Biochem Behav 1998;61:159-168.
42. Ishii Y, Blundell JE, Halford JC, Rodgers RJ. Payability, food intake and the behavioural satiety sequence in male rats. Physiol Behav 2003;80:37-47.
43. Benoit SC, Air EL, Wilmer K et al. Two novel paradigms for the simultaneous assessment of conditioned taste aversion and food intake effects of anorexic agents. Physiol Behav 2003;79:761-766.
44. Abbott CR, Small CJ, Sajedi A et al. The importance of acclimatisation and habituation to experimental conditions when investigating the anorectic effects of gastrointestinal hormones in the rat. Int J Obes (Lond) 2006;30:288-292.
45. Banks WA. The blood-brain barrier as a regulatory interface in the gut-brain axes. Physiol Behav 2006;89:472-476.
46. Mendez M, Souaze F, Nagano M et al. High affinity neurotensin receptor mRNA distribution in rat brain and peripheral tissues. Analysis by quantitative RT-PCR. J Mol Neurosci 1997;9:93-102.
47. Feurle GE, Klein A, Hamscher G, Metzger JW, Schuurkes JA. Neurokinetic and myokinetic effects of the peptide xenin on the motility of the small and large intestine of guinea pig. J Pharmacol Exp Ther 1996;278:654-661.
48. Kamiyama Y, Aihara R, Nakabayashi T et al. The peptide hormone xenin induces gallbladder contractions in conscious dogs. Neurogastroenterol Motil 2007;19:233-240.
49. Crawley JN, Beinfeld MC. Rapid development of tolerance to the behavioural actions of cholecystokinin. Nature 1983;302:703-706.